Analysts: more sales Johnson & Johnson

Tomorrow the American company Johnson & Johnson will publish its past quarter's results. Over the current book year the total revenue will be 76,32 billion USD (consensus estimates). This is slightly more than 2016's revenue of 71,89 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

The analysts expect for 2018 a net profit of 19,98 billion USD. For this year the consensus of Johnson & Johnson 's result per share is a profit of 7,28 USD. The price-earnings-ratio equals 20,24.

Per share the analysts are expecting a dividend of 3,33 USD per share. Thus the dividend yield equals 2,26 percent. The average dividend yield of the health care companies equals a limited 0,19 percent.

Newest target prices around 160 USD

The latest 3 recommendations for the health care company were provided by Jefferies & Co., RBC Capital Markets and JP Morgan.

Based on the current number of outstanding shares Johnson & Johnson 's market capitalization is 406 billion USD.

On Thursday, the stock closed at 147,36 USD.

Price data Johnson & Johnson 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.